Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-25-145

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

National Institutes of Health opportunity PAR-25-145

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-145Grants.gov
Related Grants
Health● Open
Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)
Varies
16 Jul 2029(1018d)
Health● Open
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Varies
07 Jan 2028(462d)
HealthUpcoming
BRAIN Initiative: Data Archives for the BRAIN Initiative
Varies
Health● Open
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Varies
07 Jan 2028(462d)
Funding Amount
Varies
USD
Application Deadline
7 January 2028
462 days remaining
Opens: 6 Nov 2024
Apply Now
Programme Details
Programme Code
PAR-25-145